G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/53 (2006.01) G01N 27/62 (2006.01) G01N 30/72 (2006.01) G01N 30/88 (2006.01) G01N 33/15 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2753881
Muscle degenerative diseases can be detected in the early stage and the therapeutic efficacy of a therapeutic agent and/or a therapy method for the diseases can be determined by measuring 11,15-dioxo-9.alpha.-hydroxy-2,3,4,5-tetranorprostan-1,20- dioic acid (referred to as "Tetranor-PGDM", hereinbelow) in a sample isolated from a subject.
Il est possible de détecter précocement des maladies dégénératives des muscles et de déterminer l'efficacité d'un agent et/ou d'une méthode thérapeutiques en mesurant l'acide 11,15-dioxo-9a-hydroxy-2,3,4, 5-tétranorprostan-1,20 dioïque (désigné ci-après par « Tétranor-PGDM) dans un échantillon isolé sur un sujet.
Aritake Kosuke
Kamauchi Shinya
Maruyama Toshihiko
Nakamura Akinori
Takeda Shin'ichi
Marks & Clerk
National Center Of Neurology And Psychiatry
Osaka Bioscience Institute
Taiho Pharmaceutical Co. Ltd.
LandOfFree
Method for detecting muscle degenerative diseases, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting muscle degenerative diseases, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting muscle degenerative diseases, and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1721805